Razem, ale osobno (prof. P. Clayton nr 3/2022)

Bibliografia:

1.    Levine H, Jørgensen N, Martino-Andrade A, Mendiola J, Weksler-Derri D, Mindlis I, Pinotti R, Swan SH. Temporal trends in sperm count: a systematic review and meta-regression analysis. Hum Reprod Update. 2017 Nov 1;23(6):646-659.

2.    Lv MQ, Ge P, Zhang J, Yang YQ, Zhou L, Zhou DX. Temporal trends in semen concentration and count among 327 373 Chinese healthy men from 1981 to 2019: a systematic review. Hum Reprod. 2021 Jun 18;36(7):1751-1775.
3.    Siqueira S., Ropelle A. C., Nascimento J. A. A., Fazano F. A. T., Bahamondes L. G., Gabiatti J. R., et al. (2020). Changes in seminal parameters among Brazilian men between 1995 and 2018. Sci. Rep. 10:6430.
4.    Skakkebaek N. E., Rajpert-De Meyts E., Buck Louis G. M., Toppari J., Andersson A. M., Eisenberg M. L., et al. (2016). Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol. Rev. 96 55–97.
5.    Mínguez-Alarcón L., Williams P. L., Chiu Y. H., Gaskins A. J., Nassan F. L., Dadd R., et al. (2018). Secular trends in semen parameters among men attending a fertility center between 2000 and 2017: identifying potential predictors. Environ. Int. 121(Pt 2) 1297–1303.
6.    Lokeshwar SD, Patel P, Fantus RJ, Halpern J, Chang C, Kargi AY, Ramasamy R. Decline in Serum Testosterone Levels Among Adolescent and Young Adult Men in the USA. Eur Urol Focus. 2020 Feb 18:S2405-4569(20)30062-6.
7.    Travison TG, Araujo AB, O’Donnell AB, Kupelian V, McKinlay JB. A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab. 2007;92:196-202.
8.    Bhasin S. Secular decline in male reproductive function: is manliness threatened? J Clin Endocrinol Metab. 2007;92:44-45.
9.    Chodick G, Epstein S, Shalev V. Secular trends in testosterone- findings from a large state-mandate care provider. Reprod Biol Endocrinol. 2020 Mar 9;18(1):19.
10.    Fui MN, Dupuis P, Grossmann M. Lowered testosterone in male obesity: mechanisms, morbidity and management. Asian J Androl. 2014 Mar-Apr;16(2):223-31.
11.    Leisegang K, Henkel R. The in vitro modulation of steroidogenesis by inflammatory cytokines and insulin in TM3 Leydig cells. Reprod Biol Endocrinol 16, 26 (2018).
12.    Tremellen K, McPhee N, Pearce K, Benson S, Schedlowski M, Engler H. Endotoxin-initiated inflammation reduces testosterone production in men of reproductive age. Am J Physiol Endocrinol Metab. 2018 Mar 1;314(3):E206-E213.
13.    Fox CW, Zhang L, Sohni A, Doblado M, Wilkinson MF, Chang RJ, Duleba AJ. Inflammatory Stimuli Trigger Increased Androgen Production and Shifts in Gene Expression in Theca-Interstitial Cells. Endocrinology. 2019 Dec 1;160(12):2946-2958.
14.    Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. (2006) Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 91: 4237–4245.
15.    Misichronis G, Georgopoulos NA, Marioli DJ, Armeni AK, Katsikis I, Piouka AD, Saltamavros AD, Roupas ND, Panidis D. (2012) The influence of obesity on androstenedione to testosterone ratio in women with polycystic ovary syndrome (PCOS) and hyperandrogenemia. Gynecol Endocrinol 28: 249–252.
16.    Virupasha HG, Muralidhar D, Ramakrishna J. Suicide and Suicidal Behavior among Transgender Persons. Indian J Psychol Med. 2016 Nov-Dec;38(6):505-509.
17.    Gonzalez CA, Gallego JD, Bockting WO. An examination of demographic characteristics, components of sexuality and gender, and minority stress as predictors of excessive alcohol, cannabis, and illicit (noncannabis) drug use among a large sample of transgender people in the United States. J Prim Prev. 2017 Aug; 38(4): 419–445.
18.    Dhejne C, Lichtenstein P, Boman M, Johansson ALV, Långström N, Landén M. Long-Term Follow-Up of Transsexual Persons Undergoing Sex Reassignment Surgery: Cohort Study in Sweden. PLoS One. 2011; 6(2): e16885.
19.    Liu R, Zhang C, Shi Y, Zhang F, Li L, Wang X, Ling Y, Fu H, Dong W, Shen J, Reeves A, Greenberg AS, Zhao L, Peng Y, Ding X. Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome. Front Microbiol. 2017 Feb 28;8:324.
20.    Liang Z, Di N, Li L, Yang D. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome. J Endocrinol Invest. 2021 Aug;44(8):1727-1737.
21.    Aytan AN, Bastu E, Demiral I, Bulut H, Dogan M, Buyru F. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome. Gynecol. Endocrinol. 2016, 32, 709–713.
22.    Patel, S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J. Steroid Biochem. Mol. Biol. 2018, 182, 27–36.
23.    Banaszewska B, Siakowska M, Chudzicka-Strugala I, Chang RJ, Pawelczyk L, Zwozdziak B, Spaczynski R, Duleba AJ. Elevation of markers of endotoxemia in women with polycystic ovary syndrome. Hum Reprod. 2020 Oct 1;35(10):2303-2311.
24.    González F, Mather KJ, Considine RV, Abdelhadi OA, Acton AJ. Salicylate administration suppresses the inflammatory response to nutrients and improves ovarian function in polycystic ovary syndrome. Am J Physiol Endocrinol Metab. 2020 Oct 1;319(4):E744-E752.
25.    Wan Y, Zuo T, Xu Z, Zhang F, Zhan H, Chan D, Leung T-F, Yeoh YK, Chan FKL, Chan R, Ng SC. Underdevelopment of the gut microbiota and bacteria species as non-invasive markers of prediction in children with autism spectrum disorder. Gut (2021), http://dx.doi.org/10.1136/gutjnl-2020-324015
26.    Binz T, Sikorra S, Mahrhold S. Clostridial neurotoxins: mechanism of SNARE cleavage and outlook on potential substrate specificity reengineering. Toxins (Basel). 2010 Apr;2(4):665-82.
27.    Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 2017 Apr;11(4):841-852.
28.    Marotta A, Sarno E, Del Casale A, Pane M, Mogna L, Amoruso A, Felis GE, Fiorio M. Effects of Probiotics on Cognitive Reactivity, Mood, and Sleep Quality. Front Psychiatry. 2019 Mar 27;10:164.
29.    Leyrolle Q, Cserjesi R, D G H Mulders M, Zamariola G, Hiel S, Gianfrancesco MA, Portheault D, Amadieu C, Bindels LB, Leclercq S, Rodriguez J, Neyrinck AM, Cani PD, Lanthier N, Trefois P, Bindelle J, Paquot N, Cnop M, Thissen JP, Klein O, Luminet O, Delzenne NM. Prebiotic effect on mood in obese patients is determined by the initial gut microbiota composition: A randomized, controlled trial. Brain Behav Immun. 2021 May;94:289-298.
30.    Azpiroz F, Dubray C, Bernalier-Donadille A, Cardot JM, Accarino A, Serra J, Wagner A, Respondek F, Dapoigny M. Effects of scFOS on the composition of fecal microbiota and anxiety in patients with irritable bowel syndrome: a randomized, double blind, placebo controlled study. Neurogastroenterol Motil. 2017 Feb;29(2).
31.    Desmedt O, Broers VJV, Zamariola G, Pachikian B, Delzenne N, Luminet O. Effects of prebiotics on affect and cognition in human intervention studies. Nutr Rev. 2019 Feb 1;77(2):81-95.
32.    Paiva IHR, Duarte-Silva E, Peixoto CA. The role of prebiotics in cognition, anxiety, and depression. Eur Neuropsychopharmacol. 2020 May;34:1-18.
33.    Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, Weinshenker BG, Rodriguez M, Kantarci OH, Nelson H, Murray JA, Mangalam AK. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci. Rep. 6, 28484 (2016).
34.    Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauffer U, Baranzini SE, Kümpfel T, Hohlfeld R, Krishnamoorthy G, Wekerle H. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10719-10724.
35.    Hannah R. The gut brain axis: impact of dietary fiber on a murine model of multiple sclerosis. MSc Thesis, 2019, University of British Columbia. https://open.library.ubc.ca/soa/cIRcle/collections/ubctheses/24/items/1.0378179
36.    Jensen SN, Cady NM, Shahi SK, Peterson SR, Gupta A, Gibson-Corley KN, Mangalam AK. Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis. Sci Adv. 2021 Jul 9;7(28):eabd4595.
37.    Schreihofer DA. Neuroprotection by dietary isoflavones and their role in cerebral ischemia. In Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. R. R. Watson and V. R. Preedy, Eds. (Elsevier, 2015), pp. 385–394.
38.    King R. Atlas of MS 3rd Edition. Part 1: Mapping multiple sclerosis around the world. Key epidemiology findings. https://www.msif.org/wp-content/uploads/2020/10/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf
39.    Cheng Q, Cheng XJ, Jiang GX. Multiple sclerosis in China–history and future. Mult Scler. 2009 Jun;15(6):655-60.
40.    Katz Sand I, Benn EKT, Fabian M, Fitzgerald KC, Digga E, Deshpande R, Miller A, Gallo S, Arab L. Randomized-controlled trial of a modified Mediterranean dietary program for multiple sclerosis: A pilot study. Mult Scler Relat Disord. 2019 Nov;36:101403.
41.    Falougy HE, Filova B, Ostatnikova D, Bacova Z, Bakos J. Neuronal morphology alterations in autism and possible role of oxytocin. Endocr Regul. 2019 Jan 1;53(1):46-54.
42.    Kong L, Norstedt G, Schalling M, Gissler M, Lavebratt C. The Risk of Offspring Psychiatric Disorders in the Setting of Maternal Obesity and Diabetes. Pediatrics. 2018 Sep;142(3):e20180776.
43.    Kong L, Nilsson IAK, Brismar K, Gissler M, Lavebratt C. Associations of Different Types of Maternal Diabetes and Body Mass Index With Offspring Psychiatric Disorders. JAMA Netw Open. 2020 Feb 5;3(2):e1920787.
44.    Rudolph MD, Graham AM, Feczko E, Miranda-Dominguez O, Rasmussen JM, Nardos R, Entringer S, Wadhwa PD, Buss C, Fair DA. Maternal IL-6 during pregnancy can be estimated from newborn brain connectivity and predicts future working memory in offspring. Nat Neurosci. 2018 May;21(5):765-772.
45.    Rosenberg MD. Baby brains reflect maternal inflammation. Nat Neurosci. 2018 May;21(5):651-653.
46.    Cao X, Liu K, Liu J, Liu YW, Xu L, Wang H, Zhu Y, Wang P, Li Z, Wen J, Shen C, Li M, Nie Z, Kong XJ. Dysbiotic Gut Microbiota and Dysregulation of Cytokine Profile in Children and Teens With Autism Spectrum Disorder. Front Neurosci. 2021 Feb 10;15:635925.
47.    Finegold S.M., Dowd S.E., Gontcharova V., Liu C., Henley K.E., Wolcott R.D., Youn E., Summanen P.H., Granpeesheh D., Dixon D., et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16:444–453.
48.    De Angelis M., Piccolo M., Vannini L., Siragusa S., De Giacomo A., Serrazzanetti D.I., Cristofori F., Guerzoni M.E., Gobbetti M., Francavilla R. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS ONE. 2013;8:e76993.
49.    Diaz Heijtz R., Wang S., Anuar F., Qian Y., Björkholm B., Samuelsson A., Hibberd M.L., Forssberg H., Pettersson S. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA. 2011;108:3047–3052.
50.    20. Wang Y., Kasper L.H. The role of microbiome in central nervous system disorders. Brain Behav. Immun. 2014;38:1–12.
51.    Christian L.M., Galley J.D., Hade E.M., Schoppe-Sullivan S., Kamp Dush C., Bailey M.T. Gut Microbiome Composition Is Associated with Temperament during Early Childhood. Brain. Behav. Immun. 2015;45:118–127.
52.    Acuña, I., Cerdó, T., Ruiz, A., Torres-Espínola, F. J., López-Moreno, A., Aguilera, M., Suárez, A., & Campoy, C. (2021). Infant Gut Microbiota Associated with Fine Motor Skills. Nutrients, 13(5), 1673.
53.    Sordillo J.E., Korrick S., Laranjo N., Carey V., Weinstock G.M., Gold D.R., Connor G.O. Association of the Infant Gut Microbiome With Early Childhood Neurodevelopmental Outcomes An Ancillary Study to the VDAART Randomized Clinical Trial. JAMA Netw Open. 2020;2:1–13.
54.    Rylaarsdam L, Guemez-Gamboa A. Genetic Causes and Modifiers of Autism Spectrum Disorder. Front Cell Neurosci. 2019 Aug 20;13:385.
55.    House JS, Mendez M, Maguire RL, Gonzalez-Nahm S, Huang Z, Daniels J, Murphy SK, Fuemmeler BF, Wright FA, Hoyo C. Periconceptional Maternal Mediterranean Diet Is Associated With Favorable Offspring Behaviors and Altered CpG Methylation of Imprinted Genes. Front Cell Dev Biol. 2018 Sep 7;6:107.
56.    Cerdó T, Ruíz A, Suárez A, Campoy C. Probiotic, Prebiotic, and Brain Development. Nutrients. 2017 Nov 14;9(11):1247.
57.    Turner A, Veysey M, Keely S, Scarlett C, Lucock M, Beckett EL. Interactions between Bitter Taste, Diet and Dysbiosis: Consequences for Appetite and Obesity. Nutrients. 2018 Sep 20;10(10):1336.
58.    Aoun A, Darwish F, Hamod N. The Influence of the Gut Microbiome on Obesity in Adults and the Role of Probiotics, Prebiotics, and Synbiotics for Weight Loss. Prev Nutr Food Sci. 2020 Jun 30;25(2):113-123.
59.    Kannan G, Moldovan K, Xiao JC, Yolken RH, Jones-Brando L, Pletnikov MV. Toxoplasma gondii strain-dependent effects on mouse behaviour. Folia Parasitol (Praha). 2010 Jun;57(2):151-5.
60.    Poirotte C, Kappeler PM, Ngoubangoye B, Bourgeois S, Moussodji M, Charpentier MJ. Morbid attraction to leopard urine in Toxoplasma-infected chimpanzees. Curr Biol. 2016 Feb 8;26(3):R98-9.
61.    Flegr J, Lindová J, Pivoňková V, Havlíček J. Brief Communication: Latent toxoplasmosis and salivary testosterone concentration – important confounding factors in second to fourth digit ratio studies. Am J Phys Anthropol 2008; 137:479-84
62.    Hari Dass SA, Vasudevan A, Dutta D, Soh LJT, Sapolsky RM, Vyas A. (2011). Protozoan parasite Toxoplasma gondii manipulates mate choice in rats by enhancing attractiveness of males. PLoS ONE 6:e27229.
63.    Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. (2011). The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS ONE 6:e23866.
64.    Flegr J, Markoš A. Masterpiece of epigenetic engineering – how Toxoplasma gondii reprogrammes host brains to change fear to sexual attraction. Mol Ecol. 2014 Dec;23(24):5934-6.
65.    Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS ONE 2011; 6:e23866
66.    Silva NM, Rodrigues CV, Santoro MM, Reis LFL, Alvarez-Leite JI, Gazzinelli RT. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: Induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect Immun 2002; 70:859-68.
67.    Flegr J. Does Toxoplasma infection increase sexual masochism and submissiveness? Yes and no. Commun Integr Biol. 2017 Nov 28;10(5-6):e1303590.
68.    Poulin, R. (2010). Chapter 5 – Parasite manipulation of host behavior: an update and frequently asked questions. in Advances in the Study of Behavior, eds Brockmann HJ, Roper TJ, Naguib M, Wynne-Edwards KE, Mitani JC, Leigh WS. (Burlington: Academic Press), 151–186.
69.    Parlog A, Schlüter D, Dunay IR. Toxoplasma gondii-induced neuronal alterations. Parasite Immunol. 2015 Mar;37(3):159-70.
70.    Solmi F, Hayes JF, Lewis G, Kirkbride JB. Curiosity killed the cat: no evidence of an association between cat ownership and psychotic symptoms at ages 13 and 18 years in a UK general population cohort. Psychol Med. 2017 Jul;47(9):1659-1667.
71.    Stock AK, Dajkic D, Köhling HL, von Heinegg EH, Fiedler M, Beste C. Humans with latent toxoplasmosis display altered reward modulation of cognitive control. Sci Rep. 2017 Aug 31;7(1):10170.
72.    Dubey, J.P. Outbreaks of clinical toxoplasmosis in humans: five decades of personal experience, perspectives and lessons learned. Parasites Vectors 14, 263 (2021).
73.    Halonen SK, Weiss LM. Toxoplasmosis. Handb Clin Neurol. 2013;114:125-45.